{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:05:52Z","timestamp":1775016352550,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Type 2 diabetes mellitus (T2DM) microvascular complications are a major public health issue that disproportionately affects racial\/ethnic minorities in the US. We aimed to address the limited understanding of racial\/ethnic disparities in the longitudinal natural history of microvascular complications over eight years among older adults with T2DM in the US and Canada.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From 10,251 participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) (2003\u20132009) trial, we derived 6323 participants. We examined racial\/ethnic disparities of composite microvascular complications, nephropathy, neuropathy, and retinopathy outcomes among adults of Black (<jats:italic>n<\/jats:italic>\u2009=\u20091099), White (<jats:italic>n<\/jats:italic>\u2009=\u20094071), and Other races (<jats:italic>n<\/jats:italic>\u2009=\u20091156), over 8\u00a0years. We used linear mixed-effects model with random intercept to account for intra-person correlation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our linear mixed-effects models displayed that the odds of composite microvascular complications for other race, which primarily consisted of Hispanic adults declined over a period of time [OR: 0.95 (0.93\u20130.99)]. The odds increased over time for Black [1.06 (1.03\u20131.09)] and White [1.11 (1.09\u20131.13)] adults (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Other race adults had a declining risk of microvascular complications over time. This decline was not observed among Black and White adults.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40615-025-02625-0","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:58:46Z","timestamp":1757437126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Trajectories of Type 2 Diabetes\u2013Related Microvascular Complications Across Racial\/Ethnic Groups Among Older Adults"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-3537","authenticated-orcid":false,"given":"Kaustubh V.","family":"Parab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha P.","family":"Gothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"Wilund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshal P.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea R.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"2625_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/edm2.321","volume":"5","author":"SV Arnold","year":"2022","unstructured":"Arnold SV, Khunti K, Tang F, Chen H, Nicolucci A, Gomes MB, et al. Impact of micro-and macrovascular complications of type 2 diabetes on quality of life: insights from the DISCOVER prospective cohort study. Endocrinol, Diabetes Metab. 2022;5:14. https:\/\/doi.org\/10.1002\/edm2.321.","journal-title":"Endocrinol, Diabetes Metab"},{"issue":"6","key":"2625_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/HMG\/DDAE203","volume":"34","author":"A Singh","year":"2025","unstructured":"Singh A, Bocher O, Zeggini E. Insights into the molecular underpinning of type 2 diabetes complications. Hum Mol Genet. 2025;34(6):469\u201380. https:\/\/doi.org\/10.1093\/HMG\/DDAE203.","journal-title":"Hum Mol Genet"},{"key":"2625_CR3","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1136\/bmjdrc-2020-001847","volume":"9","author":"J An","year":"2021","unstructured":"An J, Nichols GA, Qian L, Munis MA, Harrison TN, Li Z, et al. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9:1847. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001847.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2625_CR4","doi-asserted-by":"publisher","first-page":"e0000599","DOI":"10.1371\/journal.pgph.0000599","volume":"2","author":"F Aikaeli","year":"2022","unstructured":"Aikaeli F, Njim T, Gissing S, Moyo F, Alam U, Mfinanga SG, et al. Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis. PLoS Glob Public Health. 2022;2:e0000599. https:\/\/doi.org\/10.1371\/journal.pgph.0000599.","journal-title":"PLoS Glob Public Health"},{"key":"2625_CR5","doi-asserted-by":"publisher","unstructured":"Haw JS, Shah M, Turbow S, Egeolu M, Umpierrez G. Diabetes complications in racial and ethnic minority populations in the USA 2021. https:\/\/doi.org\/10.1007\/s11892-020-01369-x.","DOI":"10.1007\/s11892-020-01369-x"},{"key":"2625_CR6","doi-asserted-by":"publisher","unstructured":"Gupta R, Misra A. Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. 2016. https:\/\/doi.org\/10.1111\/1753-0407.12378.","DOI":"10.1111\/1753-0407.12378"},{"key":"2625_CR7","doi-asserted-by":"publisher","unstructured":"Garvey SL, Khansari MM, Jiang X, Varma R, Shahidi M. Assessment of retinal vascular oxygenation and morphology at stages of diabetic retinopathy in African Americans 2020. https:\/\/doi.org\/10.1186\/s12886-020-01566-y.","DOI":"10.1186\/s12886-020-01566-y"},{"key":"2625_CR8","doi-asserted-by":"publisher","unstructured":"Spanakis EK, Golden SH. Race\/ethnic difference in diabetes and diabetic complications 2013. https:\/\/doi.org\/10.1007\/s11892-013-0421-9.","DOI":"10.1007\/s11892-013-0421-9"},{"key":"2625_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/S00125-013-2873-5","volume":"56","author":"K Winkley","year":"2013","unstructured":"Winkley K, Thomas SM, Sivaprasad S, Chamley M, Stahl D, Ismail K, et al. The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: the South London Diabetes cohort (SOUL-D). Diabetologia. 2013;56:1272\u201381. https:\/\/doi.org\/10.1007\/S00125-013-2873-5.","journal-title":"Diabetologia"},{"key":"2625_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/J.JDIACOMP.2016.07.023","volume":"31","author":"N Laiteerapong","year":"2017","unstructured":"Laiteerapong N, Karter AJ, Moffet HH, Cooper JM, Gibbons RD, Liu JY, et al. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: the diabetes & aging study. J Diabetes Complicat. 2017;31:94\u2013100. https:\/\/doi.org\/10.1016\/J.JDIACOMP.2016.07.023.","journal-title":"J Diabetes Complicat"},{"key":"2625_CR11","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2215\/CJN.11871017","volume":"13","author":"C Gerber","year":"2018","unstructured":"Gerber C, Cai X, Lee J, Craven T, Scialla J, Souma N, et al. Incidence and progression of chronic kidney disease in Black and White individuals with type 2 diabetes. Clin J Am Soc Nephrol. 2018;13:884\u201392. https:\/\/doi.org\/10.2215\/CJN.11871017.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2625_CR12","doi-asserted-by":"publisher","unstructured":"Gupta DK, Walford GA, Ma Y, Id PJ, Wang TJ. Racial\/ethnic differences in circulating natriuretic peptide levels: the Diabetes Prevention Program 2020. https:\/\/doi.org\/10.1371\/journal.pone.0229280.","DOI":"10.1371\/journal.pone.0229280"},{"key":"2625_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2337\/DCI22-0044","volume":"46","author":"LE Egede","year":"2023","unstructured":"Egede LE, Campbell JA, Walker RJ, Linde S. Structural racism as an upstream social determinant of diabetes outcomes: a scoping review. Diabetes Care. 2023;46:667\u201377. https:\/\/doi.org\/10.2337\/DCI22-0044.","journal-title":"Diabetes Care"},{"key":"2625_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1377\/HLTHAFF.2021.01394","volume":"41","author":"PA Braveman","year":"2022","unstructured":"Braveman PA, Arkin E, Proctor D, Kauh T, Holm N. Systemic and structural racism: definitions, examples, health damages, and approaches to dismantling. Health Aff. 2022;41:171\u20138. https:\/\/doi.org\/10.1377\/HLTHAFF.2021.01394.","journal-title":"Health Aff"},{"key":"2625_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2337\/DC15-1323","volume":"39","author":"YY Meng","year":"2016","unstructured":"Meng YY, Diamant A, Jones J, Lin W, Chen X, Wu SH, et al. Racial and ethnic disparities in diabetes care and impact of vendor-based disease management programs. Diabetes Care. 2016;39:743\u20139. https:\/\/doi.org\/10.2337\/DC15-1323.","journal-title":"Diabetes Care"},{"key":"2625_CR16","unstructured":"Action to control cardiovascular risk in diabetes (ACCORD) public use data overview. 2007. https:\/\/biolincc.nhlbi.nih.gov\/studies\/accord\/. Accessed 26 Aug 2025."},{"key":"2625_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji M, Basile J, Calles J, Cohen R, et al. Effect of intensive treatment of hyperglycemia on microvascular complications of type 2 diabetes in ACCORD: a randomized trial. Lancet. 2010;376:419. https:\/\/doi.org\/10.1016\/S0140-6736(10)60576-4.","journal-title":"Lancet"},{"key":"2625_CR18","doi-asserted-by":"crossref","unstructured":"Stroup WW, Ptukhina M, Garai J. Generalized linear mixed models: modern concepts, methods and applications. 2024. https:\/\/www.routledge.com\/Generalized-Linear-Mixed-Models-Modern-Concepts-Methods-and-Applications\/Stroup-Ptukhina-Garai\/p\/book\/9781498755566?srsltid=AfmBOopxVKcGPTj336EOpfRWLicWdIDUFzI-sOuJlh8qCzcZyNEqp8N4. Accessed 31 Jul 2025.","DOI":"10.1201\/9780429092060"},{"key":"2625_CR19","doi-asserted-by":"publisher","first-page":"100583","DOI":"10.1016\/J.SSMPH.2020.100583","volume":"11","author":"E Arias","year":"2020","unstructured":"Arias E, Johnson NJ, Vera BT. Racial disparities in mortality in the adult Hispanic population. SSM Popul Health. 2020;11:100583. https:\/\/doi.org\/10.1016\/J.SSMPH.2020.100583.","journal-title":"SSM Popul Health"},{"key":"2625_CR20","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/DBI20-0001","volume":"69","author":"E Ahlqvist","year":"2020","unstructured":"Ahlqvist E, Prasad RB, Groop L. Subtypes of type 2 diabetes determined from clinical parameters. Diabetes. 2020;69:2086\u201393. https:\/\/doi.org\/10.2337\/DBI20-0001.","journal-title":"Diabetes"},{"key":"2625_CR21","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1210\/CLINEM\/DGAF234","volume":"110","author":"AJ Deutsch","year":"2025","unstructured":"Deutsch AJ, Udler MS. Phenotypic and genetic diversity in diabetes across populations. J Clin Endocrinol Metab. 2025;110:2123\u201333. https:\/\/doi.org\/10.1210\/CLINEM\/DGAF234.","journal-title":"J Clin Endocrinol Metab"},{"key":"2625_CR22","doi-asserted-by":"publisher","first-page":"e0290791","DOI":"10.1371\/JOURNAL.PONE.0290791","volume":"18","author":"H Dambha-Miller","year":"2023","unstructured":"Dambha-Miller H, Hounkpatin HO, Stuart B, Farmer A, Griffin S. Type 2 diabetes remission trajectories and variation in risk of diabetes complications: a population-based cohort study. PLoS ONE. 2023;18:e0290791. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0290791.","journal-title":"PLoS ONE"},{"issue":"2","key":"2625_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/S00592-014-0633-8","volume":"52","author":"I Walraven","year":"2014","unstructured":"Walraven I, Mast MR, Hoekstra T, Jansen APD, van der Heijden AAWA, Rauh SP, et al. Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta Diabetol. 2014;52(2):267\u201375. https:\/\/doi.org\/10.1007\/S00592-014-0633-8.","journal-title":"Acta Diabetol"},{"key":"2625_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jvs.2012.05.100","volume":"56","author":"JB Goldberg","year":"2012","unstructured":"Goldberg JB, Goodney PP, Cronenwett JL, Baker F. The effect of risk and race on lower extremity amputations among medicare diabetic patients. J Vasc Surg. 2012;56:1663\u20138. https:\/\/doi.org\/10.1016\/j.jvs.2012.05.100.","journal-title":"J Vasc Surg"},{"key":"2625_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00592-020-01489-6","volume":"57","author":"SS Singh","year":"2020","unstructured":"Singh SS, Roeters-van Lennep JE, Lemmers RFH, van Herpt TTW, Lieverse AG, Sijbrands EJG, et al. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study. Acta Diabetol. 2020;57:725\u201332. https:\/\/doi.org\/10.1007\/s00592-020-01489-6.","journal-title":"Acta Diabetol"},{"key":"2625_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2519","author":"AJ Karter","year":"2002","unstructured":"Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002. https:\/\/doi.org\/10.1001\/jama.287.19.2519.","journal-title":"JAMA"},{"key":"2625_CR27","doi-asserted-by":"publisher","first-page":"103089","DOI":"10.1016\/J.HEALTHPLACE.2023.103089","volume":"83","author":"CR Singleton","year":"2023","unstructured":"Singleton CR, Wright LA, McDonald M, Archer IG, Bell CN, McLoughlin GM, et al. Structural racism and geographic access to food retailers in the United States: a scoping review. Health Place. 2023;83:103089. https:\/\/doi.org\/10.1016\/J.HEALTHPLACE.2023.103089.","journal-title":"Health Place"},{"key":"2625_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/diacare.14.7.655","volume":"14","author":"RF Hamman","year":"1991","unstructured":"Hamman RF, Franklin GA, Mayer EJ, Marshall SM, Marshall JA, Baxter J, et al. Microvascular complications of NIDDM in Hispanics and non-Hispanic whites: San Luis Valley diabetes study. Diabetes Care. 1991;14:655\u201364. https:\/\/doi.org\/10.2337\/diacare.14.7.655.","journal-title":"Diabetes Care"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02625-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:58:48Z","timestamp":1757437128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02625-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":28,"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02625-0","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was deemed exempt by the University of Illinois at Urbana-Champaign IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}